Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism Mycobacterium tuberculosis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H16ClNO3 |
InChIKeySNXDJHDIXKVNFR-UHFFFAOYSA-N |
CAS Registry2413006-48-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mycobacterium Infections | Preclinical | BR | 04 Dec 2024 |